Literature DB >> 25979977

Induction Therapy in Renal Transplantation: Why? What Agent? What Dose? We May Never Know.

Alexander C Wiseman1.   

Abstract

Entities:  

Keywords:  basiliximab; induction therapy; live donor; thymoglobulin; transplantation

Mesh：

Substances：

Year:  2015        PMID： 25979977      PMCID： PMC4455201          DOI： 10.2215/CJN.03800415

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  15 in total

1.  OPTN/SRTR 2013 Annual Data Report: kidney.

Authors:  A J Matas; J M Smith; M A Skeans; B Thompson; S K Gustafson; D E Stewart; W S Cherikh; J L Wainright; G Boyle; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2015-01       Impact factor: 8.086

2.  Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.

Authors:  Bekir Tanriover; Song Zhang; Malcolm MacConmara; Ang Gao; Burhaneddin Sandikci; Mehmet U S Ayvaci; Mutlu Mete; Demetra Tsapepas; Nilum Rajora; Prince Mohan; Ronak Lakhia; Christopher Y Lu; Miguel Vazquez
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-15       Impact factor: 8.237

3.  The risk of acute rejection and the influence of induction agents in lower-risk African American kidney transplant recipients receiving modern immunosuppression.

Authors:  Jane Gralla; Charles N Le; James E Cooper; Alexander C Wiseman
Journal:  Clin Transplant       Date:  2014-01-30       Impact factor: 2.863

4.  Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experience.

Authors:  Karen L Hardinger; Mark A Schnitzler; Matthew J Koch; Emily Labile; Paula M Stirnemann; Brent Miller; Decha Enkvetchakul; Daniel C Brennan
Journal:  Transplantation       Date:  2006-05-15       Impact factor: 4.939

5.  Alemtuzumab induction in renal transplantation.

Authors:  Michael J Hanaway; E Steve Woodle; Shamkant Mulgaonkar; V Ram Peddi; Dixon B Kaufman; M Roy First; Richard Croy; John Holman
Journal:  N Engl J Med       Date:  2011-05-19       Impact factor: 91.245

6.  Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients.

Authors:  V Ram Peddi; Margaret Bryant; Prabir Roy-Chaudhury; E Steve Woodle; M Roy First
Journal:  Transplantation       Date:  2002-05-15       Impact factor: 4.939

7.  Polyclonal antithymocyte globulin and cardiovascular disease in kidney transplant recipients.

Authors:  Didier Ducloux; Cécile Courivaud; Jamal Bamoulid; Thomas Crepin; Jean-Marc Chalopin; Pierre Tiberghien; Philippe Saas
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

8.  The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomes.

Authors:  Kaiyin Wu; Klemens Budde; Huber Lu; Danilo Schmidt; Lutz Liefeldt; Petra Glander; Hans Helmut Neumayer; Birgit Rudolph
Journal:  Transplantation       Date:  2014-06-15       Impact factor: 4.939

Review 9.  Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation.

Authors:  Chris Wiebe; Peter Nickerson
Journal:  Curr Opin Organ Transplant       Date:  2013-08       Impact factor: 2.640

10.  A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes.

Authors:  R Brian Stevens; Kirk W Foster; Clifford D Miles; James T Lane; Andre C Kalil; Diana F Florescu; John P Sandoz; Theodore H Rigley; Kathleen J Nielsen; Jill Y Skorupa; Anna M Kellogg; Tamer Malik; Lucile E Wrenshall
Journal:  Transplantation       Date:  2015-01       Impact factor: 4.939
View more
  12 in total

1.  Induction Therapy in Immunologically Well-Matched Recipients: Less May Be More.

Authors:  Vishnu S Potluri; Roy D Bloom
Journal:  Clin J Am Soc Nephrol       Date:  2022-02       Impact factor: 10.614

2.  Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and Mycophenolate.

Authors:  Bekir Tanriover; Vishal Jaikaransingh; Malcolm P MacConmara; Justin R Parekh; Swee-Ling Levea; Venkatesh K Ariyamuthu; Song Zhang; Ang Gao; Mehmet U S Ayvaci; Burhaneddin Sandikci; Nilum Rajora; Vaqar Ahmed; Christopher Y Lu; Sumit Mohan; Miguel A Vazquez
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-30       Impact factor: 8.237

3.  Rabbit anti-thymocyte globulin (rATG) versus IL-2 receptor antagonist induction therapies in tacrolimus-based immunosuppression era: a meta-analysis.

Authors:  Hatem Ali; Karim M Soliman; Ihab Shaheen; Jon Jin Kim; Mohsen El Kossi; Ajay Sharma; Ravi Pararajasingam; Ahmed Halawa
Journal:  Int Urol Nephrol       Date:  2020-03-13       Impact factor: 2.370

4.  Effects of anti-human T lymphocyte immune globulins in patients: new or old.

Authors:  Diane C Wang; Xiangdong Wang; Chengshui Chen
Journal:  J Cell Mol Med       Date:  2016-04-15       Impact factor: 5.310

5.  Precision Medicine in Kidney Transplantation: Just Hype or a Realistic Hope?

Authors:  Ehsan Nobakht; Muralidharan Jagadeesan; Rohan Paul; Jonathan Bromberg; Sherry Dadgar
Journal:  Transplant Direct       Date:  2021-01-07

6.  The Impact of Different Induction Immunosuppressive Therapy on Long-Term Kidney Transplant Function When Measured by Iothalamate Clearance.

Authors:  Tambi Jarmi; Samir Khouzam; Nitika Shekhar; Meray Hosni; Launia White; David O Hodge; Martin L Mai; Hani M Wadei
Journal:  J Clin Med Res       Date:  2020-12-18

7.  Effects of Reduced-Dose Anti-Human T-Lymphocyte Globulin on Overall and Donor-Specific T-Cell Repertoire Reconstitution in Sensitized Kidney Transplant Recipients.

Authors:  Constantin Aschauer; Kira Jelencsics; Karin Hu; Mariella Gregorich; Roman Reindl-Schwaighofer; Sabine Wenda; Thomas Wekerle; Andreas Heinzel; Rainer Oberbauer
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

Review 8.  Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usage.

Authors:  Paolo Malvezzi; Thomas Jouve; Lionel Rostaing
Journal:  J Nephropathol       Date:  2015-10-01

9.  Erythrocyte glutathione transferase in kidney transplantation: a probe for kidney detoxification efficiency.

Authors:  Alessio Bocedi; Annalisa Noce; Valentina Rovella; Giulia Marrone; Giada Cattani; Massimo Iappelli; Paolo De Paolis; Giuseppe Iaria; Daniele Sforza; Mariacarla Gallù; Giuseppe Tisone; Nicola Di Daniele; Giorgio Ricci
Journal:  Cell Death Dis       Date:  2018-02-19       Impact factor: 8.469

10.  Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation.

Authors:  Rita R Alloway; E Steve Woodle; Daniel Abramowicz; Dorry L Segev; Remi Castan; Jillian N Ilsley; Kari Jeschke; Kenneth Troy Somerville; Daniel C Brennan
Journal:  Am J Transplant       Date:  2019-04-03       Impact factor: 8.086
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.